Canada markets closed

Theravance Biopharma, Inc. (TBPH)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
9.54-0.06 (-0.63%)
At close: 04:00PM EDT
9.54 0.00 (0.00%)
After hours: 04:06PM EDT
Currency in USD

Valuation Measures4

Market Cap (intraday) 466.18M
Enterprise Value 412.91M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)9.25
Price/Book (mrq)2.19
Enterprise Value/Revenue 7.19
Enterprise Value/EBITDA -9.68

Trading Information

Stock Price History

Beta (5Y Monthly) 0.35
52-Week Change 3-15.64%
S&P500 52-Week Change 325.77%
52 Week High 311.98
52 Week Low 38.21
50-Day Moving Average 39.11
200-Day Moving Average 39.60

Share Statistics

Avg Vol (3 month) 3408.68k
Avg Vol (10 day) 3533.04k
Shares Outstanding 548.56M
Implied Shares Outstanding 648.56M
Float 814.38M
% Held by Insiders 114.51%
% Held by Institutions 1106.26%
Shares Short (Apr 15, 2024) 46.43M
Short Ratio (Apr 15, 2024) 414.32
Short % of Float (Apr 15, 2024) 426.03%
Short % of Shares Outstanding (Apr 15, 2024) 413.24%
Shares Short (prior month Mar 15, 2024) 48.4M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Dec 31, 2023

Profitability

Profit Margin -96.11%
Operating Margin (ttm)-35.53%

Management Effectiveness

Return on Assets (ttm)-6.73%
Return on Equity (ttm)-16.86%

Income Statement

Revenue (ttm)57.42M
Revenue Per Share (ttm)1.04
Quarterly Revenue Growth (yoy)19.90%
Gross Profit (ttm)N/A
EBITDA -53.19M
Net Income Avi to Common (ttm)-55.19M
Diluted EPS (ttm)-1.00
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)102.43M
Total Cash Per Share (mrq)2.13
Total Debt (mrq)49.16M
Total Debt/Equity (mrq)23.08%
Current Ratio (mrq)5.39
Book Value Per Share (mrq)4.43

Cash Flow Statement

Operating Cash Flow (ttm)-27M
Levered Free Cash Flow (ttm)-13.89M